Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study

Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study

Abstract Background The purpose of this study was to determine the prevalence of high disease activity as measured using the Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients who nonetheless have low Bath Ankylosing Spondylitis Disease Activity Index (BASD...

Full description

Bibliographic Details
Main Authors: Bora Nam, Bon San Koo, Tae-Han Lee, Ji-Hui Shin, Jin-Ju Kim, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Musculoskeletal Disorders
Subjects:
Ankylosing spondylitis
Disease activity
Ankylosing spondylitis disease activity score (ASDAS)
Bath Ankylosing spondylitis disease activity index (BASDAI)
Anti-tumor necrosis factor (anti-TNF)
Online Access:https://doi.org/10.1186/s12891-020-03941-8

Internet

https://doi.org/10.1186/s12891-020-03941-8

Similar Items